These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 23312829

  • 1. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.
    Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Frost M, Belousova E, Sauter M, Nonomura N, Brakemeier S, de Vries PJ, Whittemore VH, Chen D, Sahmoud T, Shah G, Lincy J, Lebwohl D, Budde K.
    Lancet; 2013 Mar 09; 381(9869):817-24. PubMed ID: 23312829
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.
    Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, Witt O, Kohrman MH, Flamini JR, Wu JY, Curatolo P, de Vries PJ, Whittemore VH, Thiele EA, Ford JP, Shah G, Cauwel H, Lebwohl D, Sahmoud T, Jozwiak S.
    Lancet; 2013 Jan 12; 381(9861):125-32. PubMed ID: 23158522
    [Abstract] [Full Text] [Related]

  • 3. Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial.
    Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Frost M, Belousova E, Sauter M, Nonomura N, Brakemeier S, de Vries PJ, Berkowitz N, Miao S, Segal S, Peyrard S, Budde K.
    Nephrol Dial Transplant; 2016 Jan 12; 31(1):111-9. PubMed ID: 26156073
    [Abstract] [Full Text] [Related]

  • 4. Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study.
    Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Belousova E, Frost MD, Sauter M, Brakemeier S, de Vries PJ, Berkowitz N, Voi M, Peyrard S, Budde K.
    PLoS One; 2017 Jan 12; 12(8):e0180939. PubMed ID: 28792952
    [Abstract] [Full Text] [Related]

  • 5. The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1.
    Kingswood JC, Jozwiak S, Belousova ED, Frost MD, Kuperman RA, Bebin EM, Korf BR, Flamini JR, Kohrman MH, Sparagana SP, Wu JY, Brechenmacher T, Stein K, Berkowitz N, Bissler JJ, Franz DN.
    Nephrol Dial Transplant; 2014 Jun 12; 29(6):1203-10. PubMed ID: 24729041
    [Abstract] [Full Text] [Related]

  • 6. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.
    Bissler JJ, McCormack FX, Young LR, Elwing JM, Chuck G, Leonard JM, Schmithorst VJ, Laor T, Brody AS, Bean J, Salisbury S, Franz DN.
    N Engl J Med; 2008 Jan 10; 358(2):140-51. PubMed ID: 18184959
    [Abstract] [Full Text] [Related]

  • 7. Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study.
    Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, Witt O, Kohrman MH, Flamini JR, Wu JY, Curatolo P, de Vries PJ, Berkowitz N, Anak O, Niolat J, Jozwiak S.
    Lancet Oncol; 2014 Dec 10; 15(13):1513-1520. PubMed ID: 25456370
    [Abstract] [Full Text] [Related]

  • 8. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.
    French JA, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, Curatolo P, de Vries PJ, Dlugos DJ, Berkowitz N, Voi M, Peyrard S, Pelov D, Franz DN.
    Lancet; 2016 Oct 29; 388(10056):2153-2163. PubMed ID: 27613521
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and pharmacodynamics of everolimus in patients with renal angiomyolipoma and tuberous sclerosis complex or lymphangioleiomyomatosis.
    Budde K, Zonnenberg BA, Frost M, Cheung W, Urva S, Brechenmacher T, Stein K, Chen D, Kingswood JC, Bissler JJ.
    Br J Clin Pharmacol; 2016 May 29; 81(5):958-70. PubMed ID: 26580489
    [Abstract] [Full Text] [Related]

  • 10. Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis.
    Bissler JJ, Nonomura N, Budde K, Zonnenberg BA, Fischereder M, Voi M, Louveau AL, Herbst F, Bebin EM, Curatolo P, Zonta A, Belousova E.
    PLoS One; 2018 May 29; 13(9):e0201005. PubMed ID: 30192751
    [Abstract] [Full Text] [Related]

  • 11. Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial.
    Cai Y, Guo H, Wang W, Li H, Sun H, Shi B, Zhang Y.
    Orphanet J Rare Dis; 2018 Mar 27; 13(1):43. PubMed ID: 29587809
    [Abstract] [Full Text] [Related]

  • 12. Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial.
    Davies DM, de Vries PJ, Johnson SR, McCartney DL, Cox JA, Serra AL, Watson PC, Howe CJ, Doyle T, Pointon K, Cross JJ, Tattersfield AE, Kingswood JC, Sampson JR.
    Clin Cancer Res; 2011 Jun 15; 17(12):4071-81. PubMed ID: 21525172
    [Abstract] [Full Text] [Related]

  • 13. Rapamycin and rapalogs for tuberous sclerosis complex.
    Sasongko TH, Ismail NF, Zabidi-Hussin Z.
    Cochrane Database Syst Rev; 2016 Jul 13; 7(7):CD011272. PubMed ID: 27409709
    [Abstract] [Full Text] [Related]

  • 14. The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma.
    Bissler JJ, Franz DN, Frost MD, Belousova E, Bebin EM, Sparagana S, Berkowitz N, Ridolfi A, Kingswood JC.
    Pediatr Nephrol; 2018 Jan 13; 33(1):101-109. PubMed ID: 28993887
    [Abstract] [Full Text] [Related]

  • 15. Commentary on: everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.
    Black P.
    Urology; 2013 Aug 13; 82(2):278-9. PubMed ID: 23642941
    [No Abstract] [Full Text] [Related]

  • 16. Re: everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.
    Laguna MP.
    J Urol; 2014 Mar 13; 191(3):626-7. PubMed ID: 24522027
    [No Abstract] [Full Text] [Related]

  • 17. Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2.
    Bissler JJ, Budde K, Sauter M, Franz DN, Zonnenberg BA, Frost MD, Belousova E, Berkowitz N, Ridolfi A, Christopher Kingswood J.
    Nephrol Dial Transplant; 2019 Jun 01; 34(6):1000-1008. PubMed ID: 30053159
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of sirolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: a systematic review.
    Peng ZF, Yang L, Wang TT, Han P, Liu ZH, Wei Q.
    J Urol; 2014 Nov 01; 192(5):1424-30. PubMed ID: 24813310
    [Abstract] [Full Text] [Related]

  • 19. Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial.
    Curatolo P, Franz DN, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, de Vries PJ, Dlugos DJ, Fan J, Ridolfi A, Pelov D, Voi M, French JA.
    Lancet Child Adolesc Health; 2018 Jul 01; 2(7):495-504. PubMed ID: 30169322
    [Abstract] [Full Text] [Related]

  • 20. Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study.
    Franz DN, Belousova E, Sparagana S, Bebin EM, Frost MD, Kuperman R, Witt O, Kohrman MH, Flamini JR, Wu JY, Curatolo P, de Vries PJ, Berkowitz N, Niolat J, Jóźwiak S.
    PLoS One; 2016 Jul 01; 11(6):e0158476. PubMed ID: 27351628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.